The Role of Phosphorylation/Dephosphorylation in Agonist-Induced Desensitization of D1 Dopamine Receptor Function: Evidence for a Novel Pathway for Receptor Dephosphorylation-Reference-Cited by-同舟云学术

The Role of Phosphorylation/Dephosphorylation in Agonist-Induced Desensitization of D1 Dopamine Receptor Function: Evidence for a Novel Pathway for Receptor Dephosphorylation

Published:2001-02-01 Issue:2 Volume:59 Page:310-321
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Gardner Ben,Liu Zhi Fang,Jiang Dong,Sibley David R.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference36 articles.

1. Agonist-induced morphologic decrease in cellular d1A dopamine receptor staining

2. Desensitization of DA1 dopamine receptors coupled to adenylyl cyclase in opossum kidney cells.;Bates;Am J Physiol,1991

3. Cyclic AMP-Mediated Desensitization of D1 Dopamine Receptor-Coupled Adenylyl Cyclase in NS20Y Neuroblastoma Cells

4. Ligand-induced Phosphorylation/Dephosphorylation of the Endogenous Bradykinin B2 Receptor from Human Fibroblasts

5. Carter AN (1995) Post-translational modification: Phosphorylation and phosphatases. in Current Protocols in Protein Science, eds Coligan JE Dunn BM Ploegh KL Speicher DW Eingfield PT (John Wiley & Son, Inc. New York), pp 13.8.11–13.8.15.

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetic Model for the Desensitization of G Protein-Coupled Receptor;The Journal of Physical Chemistry Letters;2024-06-04

2. Kinetic model for the desensitization of G protein-coupled receptor;2024-04-01

3. Delineation of G Protein-Coupled Receptor Kinase Phosphorylation Sites within the D1 Dopamine Receptor and Their Roles in Modulating β-Arrestin Binding and Activation;International Journal of Molecular Sciences;2023-04-01

4. Posttranslational Control of GPCR Signaling;GPCRs as Therapeutic Targets;2022-09-16

5. Dopamine Receptors: Neurotherapeutic Targets for Substance Use Disorders;GPCRs as Therapeutic Targets;2022-09-16